Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of fimasartan + amlodipine in essential hypertension
KCT0000192Phase 2Recruiting
- Sponsor
- Boryung
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fimasartan, amlodipine in essential hypertension, sponsored by Boryung. Started Sep 2011; status: recruiting.
02
Drugs
fimasartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on KCT0000192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000192.